Testing the SNOWDROP Intervention: Using a Clinical Decision Support System and Patient Portal for Falls Prevention Among Older Patients in Primary Care (SNOWDROP)

January 9, 2024 updated by: Julia van Weert, University of Amsterdam

Seniors Empowered Via Big Data to Joint-manage Their Medication-related Risk of Falling in Primary Care

Falls are a leading cause of injuries among older patients. Medication use is a major risk factor for falls. Because we lack tools to assess individualized risks, general practitioners (GPs) struggle with fall-related medication management for older patients. Furthermore, these older patients are often not properly equipped to engage in the joint management of their medication. A Clinical Decision Support System (CDSS) for GPs and a patient portal for older patients may stimulate shared decision making between GPs and older patients when discussing the medication-related fall risk. The CDSS provides the GP with advice on how to alter medication in such a way that the fall risk decreases, and the patient portal helps the older patient to prepare for a consultation and to engage in the joint management of their medication.

Study Overview

Study Type

Interventional

Enrollment (Actual)

85

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amsterdam, Netherlands
        • Huisartsenpraktijken

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Aged 70 years or older
  • High fall risk
  • Takes at least 1 Fall Risk Increasing Drug (FRID)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention condition
A Clinical Decision Support System (CDSS) that calculates older patients' personalized fall risk and provides the GP with advice on how to adjust the patient's medication in order to lower the fall risk.
A patient portal that provides general information on falls and fall risk to the older patients and helps the patient to prepare for the consultation by filling out a Question Prompt List (QPL). The QPL is a list of possibly relevant questions and topics from which the patient can select those that are important to him/her. These will already be sent to the GP before the consultation takes place.
No Intervention: Control condition

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shared decision making
Time Frame: During consultation
This concerns the extent to which shared decision making between patient and GP during the consultation. This will be assessed using the Observer OPTION Multiple Chronic Conditions (OPTION-MCC). Consultation are audiotaped and will be coded on shared decision making using this coding scheme.
During consultation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technology Acceptance Model (TAM; patient portal)
Time Frame: At baseline & two weeks after consultation
The Technology Acceptance Model (TAM) measures the adoption of a new technology/system based on user attitudes in relation to the patient portal.
At baseline & two weeks after consultation
Website Satisfaction Scale (WSS; patient portal)
Time Frame: At baseline & two weeks after consultation
The Website Satisfaction Scale (WSS) measures satisfaction with comprehensibility, satisfaction with attractiveness, and satisfaction with emotional support, in relation to the patient portal.
At baseline & two weeks after consultation
Patient portal usage
Time Frame: At baseline & two weeks after consultation
Patients are asked if they used the patient portal and which components they used.
At baseline & two weeks after consultation
Beliefs About Medicines Questionnaire (BMQ)
Time Frame: Baseline & two weeks after consultation
The Beliefs about Medicines Questionnaire measures beliefs about the necessity of medication and concerns about medication.
Baseline & two weeks after consultation
Netherlands Patient Information Recall Questionnaire (NPIRQ)
Time Frame: Two weeks after consultation
The Netherlands Patient Information Recall Questionnaire consists of open questions measuring patients' recall of what was discussed and decided during the consultation.
Two weeks after consultation
Decisional Conflict Scale (DCS)
Time Frame: Two weeks after consultation
The decisional conflict scale measures decisional conflict after the consultation related to five subscales: feeling informed, uncertainty, values clarity, support, and effective decision making.
Two weeks after consultation
Changes in medication
Time Frame: Baseline & two weeks after the consultation
Changes in prescriptions of the medication as reported in the electronic health record.
Baseline & two weeks after the consultation
Technology Acceptance Model (TAM; CDSS)
Time Frame: After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
The Technology Acceptance Model (TAM) measures the adoption of a new technology/system based on user attitudes in relation to the CDSS to be answered by the GP. This is assessed by measuring Perceived Usefulness, Perceived Ease of Use, and Intention to use.
After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
The Website Satisfaction Scale (WSS; CDSS)
Time Frame: After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
The Website Satisfaction Scale (WSS) measures satisfaction with comprehensibility, satisfaction with attractiveness, and satisfaction with emotional support, in relation to the CDSS to be answered by the GP.
After the first consultation (study beginning) and after the last consultation (study completion after +/- 7 months)
Evaluation of the consultation
Time Frame: Immediately after each consultation
Four items to assess the consultation to be answered by the GP. The items assess to what extent the patient was representative, their opinion on the communication during the consultation, the extent to which they are satisfied with any decisions made and the difficulty of the consultation.
Immediately after each consultation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julia C.M. van Weert, Amsterdam School for Communication Research (ASCoR), University of Amsterdam

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2022

Primary Completion (Actual)

October 30, 2023

Study Completion (Actual)

October 30, 2023

Study Registration Dates

First Submitted

October 18, 2022

First Submitted That Met QC Criteria

November 3, 2022

First Posted (Actual)

November 9, 2022

Study Record Updates

Last Update Posted (Actual)

January 10, 2024

Last Update Submitted That Met QC Criteria

January 9, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-PC-15274

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Currently no plan

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deprescribing

Clinical Trials on CDSS

Subscribe